PMID: 9539131Apr 16, 1998Paper

Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

Neuron
C L LinJ D Rothstein

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that is characterized by selective upper and lower motor neuron degeneration, the pathogenesis of which is unknown. About 60%-70% of sporadic ALS patients have a 30%-95% loss of the astroglial glutamate transporter EAAT2 (excitatory amino acid transporter 2) protein in motor cortex and spinal cord. Loss of EAAT2 leads to increased extracellular glutamate and excitotoxic neuronal degeneration. Multiple abnormal EAAT2 mRNAs, including intron-retention and exon-skipping, have now been identified from the affected areas of ALS patients. The aberrant mRNAs were highly abundant and were found only in neuropathologically affected areas of ALS patients but not in other brain regions. They were found in 65% of sporadic ALS patients but were not found in nonneurologic disease or other disease controls. They were also detectable in the cerebrospinal fluid (CSF) of living ALS patients, early in the disease. In vitro expression studies suggest that proteins translated from these aberrant mRNAs may undergo rapid degradation and/ or produce a dominant negative effect on normal EAAT2 resulting in loss of protein and activity. These findings suggest that the loss of EAAT2 in ALS...Continue Reading

References

Dec 10, 1992·The New England Journal of Medicine·R G SmithS H Appel
May 28, 1992·The New England Journal of Medicine·J D RothsteinR W Kuncl
Jul 1, 1990·Annals of Neurology·J D RothsteinJ T Coyle
Jun 1, 1995·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·P J ShawH J Wastell
Jul 1, 1995·Annals of Neurology·J D RothsteinR W Kuncl
May 1, 1995·Journal of Neurochemistry·A C BowlingR H Brown
Jul 1, 1994·Journal of the Neurological Sciences·S H AppelE Stefani
Jul 1, 1994·Journal of the Neurological Sciences·P J Shaw
Sep 1, 1994·Neuron·J D RothsteinR W Kuncl
Apr 14, 1994·Neuroreport·P CouratierJ Hugon
Aug 1, 1993·Neuropathology and Applied Neurobiology·P InceK G Baimbridge
Mar 3, 1994·The New England Journal of Medicine·G BensimonV Meininger
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J D RothsteinR W Kuncl
May 1, 1996·Annals of Neurology·L A Bristol, J D Rothstein
Mar 15, 1996·The Journal of Biological Chemistry·D TrottiA Volterra
Jul 15, 1996·The Journal of Clinical Investigation·J A KuivenhovenJ J Kastelein
Oct 1, 1996·Neurology·J D Rothstein
Jan 1, 1996·Human Molecular Genetics·T Siddique, H X Deng
Nov 1, 1996·The Journal of Biological Chemistry·O HaugetoN C Danbolt
Oct 1, 1996·Neuropathology and Applied Neurobiology·L I Bruijn, D W Cleveland
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·M MorrisonM B Roth

❮ Previous
Next ❯

Citations

Mar 21, 2000·Journal of Neuroscience Research·M E AlexianuS H Appel
Jan 3, 2001·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·C Perrone CapanoU di Porzio
May 29, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·M NeystatR E Burke
Sep 29, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·E Jaros, D J Burn
Mar 27, 2001·Muscle & Nerve·A Eisen, M Weber
Apr 24, 2001·Muscle & Nerve·E A Fon, R H Edwards
Sep 24, 1999·Molecular Neurobiology·T J Kilpatrick, M Soilu-Hänninen
Sep 1, 2004·Pflügers Archiv : European journal of physiology·Nicola J AllenDavid Attwell
Mar 20, 2002·Current Neurology and Neuroscience Reports·C E ShawN Leigh
Nov 30, 2000·Current Treatment Options in Neurology·B M Demaerschalk, M J Strong
Jan 31, 2006·Brain Research·Mitsunori WatanabeKoichi Okamoto
Nov 13, 2003·European Journal of Pharmacology·Yoshikatsu Kanai, Matthias A Hediger
Apr 2, 2004·Neurobiology of Disease·Nicholas J Maragakis, Jeffrey D Rothstein
Nov 21, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Swati Aggarwal, Merit Cudkowicz
Oct 1, 2010·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Marcelo R Vargas, Jeffrey A Johnson
Dec 31, 2003·Trends in Neurosciences·Shyam D Rao, John H Weiss
Feb 15, 2001·European Journal of Pharmacology·D MaimoneL M Grimaldi
Oct 26, 2001·Journal of the Neurological Sciences·J Karitzky, A C Ludolph
Dec 14, 1999·Journal of the Neurological Sciences·V SilaniG Scarlato
Jul 16, 2002·Pharmacology, Biochemistry, and Behavior·Alessandra ValerioPierFranco Spano
Jun 5, 2003·Pharmacology & Therapeutics·Michael J Strong
Feb 12, 1999·Brain Research. Brain Research Reviews·B M Morrison, J H Morrison
Aug 28, 1998·Trends in Neurosciences·F W van LeeuwenE M Hol
May 10, 2000·Neuroscience Research·K Tanaka
Oct 19, 2000·Brain Research. Molecular Brain Research·C MünchT Meyer
Nov 14, 1998·Brain Research. Molecular Brain Research·S Kiryu-SeoH Kiyama
Dec 5, 1998·Brain Research. Molecular Brain Research·C L LinJ D Rothstein
Dec 10, 2002·Neurochemistry International·Amie L JimenezBruce D Howard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Researcher Network:CZI Neurodegeneration Challenge

The Neurodegeneration Challenge Network aims to provide funding for and to bring together researchers studying neurodegenerative diseases. Find the latest research from the NDCN grantees here.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.